74 related articles for article (PubMed ID: 25130897)
1. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
[TBL] [Abstract][Full Text] [Related]
2. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
Momose H; Kurita N; Nishikii H; Yusa N; Yokoyama K; Shimizu E; Imoto S; Nanmoku T; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Matsuoka R; Obara N; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2024; 65(1):35-40. PubMed ID: 38311387
[TBL] [Abstract][Full Text] [Related]
3. T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Vardell VA; Ermann DA; Fitzgerald L; Shah H; Hu B; Stephens DM
Am J Hematol; 2024 Mar; 99(3):494-496. PubMed ID: 38240336
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of prolymphoblastic leukemia: the rare hematological malignancy in the elderly.
Yan Z; Zeng M; Chen X; Yin Y; Liu Y
Am J Transl Res; 2023; 15(9):5653-5663. PubMed ID: 37854229
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and survival outcomes of patients with T cell prolymphocytic leukemia in the United States: 2011-2020 analysis of the SEER database.
Wasifuddin M; Ilerhunmwuwa NP; Becerra H; Wang JC
Leuk Lymphoma; 2023 Dec; 64(12):2051-2053. PubMed ID: 37531079
[No Abstract] [Full Text] [Related]
6. On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
Leroyer EH; Petitpain N; Morisset S; Neven B; Castelle M; Winter S; Souchet L; Morel V; Le Cann M; Fahd M; Yacouben K; Mechinaud F; Ouachée-Chardin M; Renard C; Wallet HL; Angoso M; Jubert C; Chevallier P; Léger A; Rialland F; Dhedin N; Robin C; Maury S; Beckerich F; Beauvais D; Cluzeau T; Loschi M; Fernster A; Bittencourt MC; Cravat M; Bilger K; Clément L; Decot V; Gauthier M; Legendre A; Larghero J; Ouedrani A; Martin-Blondel G; Pochon C; Reppel L; Rouard H; Nguyen-Quoc S; Dalle JH; D'Aveni M; Bensoussan D
Hemasphere; 2024 Jan; 8(1):e40. PubMed ID: 38434523
[No Abstract] [Full Text] [Related]
7. T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus.
Rashidi A; Fisher SI
Eur J Haematol; 2015 Sep; 95(3):199-210. PubMed ID: 25846234
[TBL] [Abstract][Full Text] [Related]
8. Are we improving the outcome for patients with T-cell prolymphocytic leukemia by allogeneic stem cell transplantation?
Herling M
Eur J Haematol; 2015 Mar; 94(3):191-2. PubMed ID: 25712069
[No Abstract] [Full Text] [Related]
9. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.
Chen YB; Batchelor T; Li S; Hochberg E; Brezina M; Jones S; Del Rio C; Curtis M; Ballen KK; Barnes J; Chi AS; Dietrich J; Driscoll J; Gertsner ER; Hochberg F; LaCasce AS; McAfee SL; Spitzer TR; Nayak L; Armand P
Cancer; 2015 Jan; 121(2):226-33. PubMed ID: 25204639
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
[TBL] [Abstract][Full Text] [Related]
11. EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).
Wiktor-Jedrzejczak W; Drozd-Sokolowska J; Eikema DJ; Hoek J; Potter M; Wulf G; Sellner L; Ljungman P; Chevallier P; Volin L; Koc Y; Martin S; Bunjes D; Rovira M; Itälä-Remes M; Foá R; Deconinck E; Gedde-Dahl T; Cornelissen J; Collin M; Brecht A; Patel A; de Groot M; Reményi P; Nagler A; Finke J; Turlure P; Iacobelli S; van Biezen A; Schetelig J; Kröger N; Dreger P
Bone Marrow Transplant; 2019 Sep; 54(9):1391-1398. PubMed ID: 30664723
[TBL] [Abstract][Full Text] [Related]
12. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
Pflug N; Cramer P; Robrecht S; Bahlo J; Westermann A; Fink AM; Schrader A; Mayer P; Oberbeck S; Seiler T; Zenz T; Dürig J; Kreuzer KA; Stilgenbauer S; Eichhorst B; Hallek M; Herling M; Hopfinger G
Leuk Lymphoma; 2019 Mar; 60(3):649-657. PubMed ID: 30234404
[TBL] [Abstract][Full Text] [Related]
13. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
Jain P; Aoki E; Keating M; Wierda WG; O'Brien S; Gonzalez GN; Ferrajoli A; Jain N; Thompson PA; Jabbour E; Kanagal-Shamanna R; Pierce S; Alousi A; Hosing C; Khouri I; Estrov Z; Cortes J; Kantarjian H; Ravandi F; Kadia TM
Ann Oncol; 2017 Jul; 28(7):1554-1559. PubMed ID: 28379307
[TBL] [Abstract][Full Text] [Related]
14. Advances and Perspectives in the Treatment of T-PLL.
Braun T; von Jan J; Wahnschaffe L; Herling M
Curr Hematol Malig Rep; 2020 Apr; 15(2):113-124. PubMed ID: 32034661
[TBL] [Abstract][Full Text] [Related]
15. Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Drozd-Sokolowska J; Gras L; Koster L; Martino R; Salas MQ; Salmenniemi U; Zudaire T; Yañez L; Bellido M; Collin M; Kaufmann M; Kozlowski P; Poiré X; Ferra C; Sampol A; Wilson KMO; Cairoli A; Gedde-Dahl T; Deconinck E; Mirabile M; Suarez F; Raj K; Van Gelder M; Yakoub-Agha I; Tournilhac O; McLornan DP
Haematologica; 2024 May; 109(5):1608-1613. PubMed ID: 38205539
[No Abstract] [Full Text] [Related]
16. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479
[TBL] [Abstract][Full Text] [Related]
17. Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia.
Varadarajan I; Ballen K
Front Oncol; 2022; 12():781479. PubMed ID: 35223471
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Murthy HS; Ahn KW; Estrada-Merly N; Alkhateeb HB; Bal S; Kharfan-Dabaja MA; Dholaria B; Foss F; Gowda L; Jagadeesh D; Sauter C; Abid MB; Aljurf M; Awan FT; Bacher U; Badawy SM; Battiwalla M; Bredeson C; Cerny J; Chhabra S; Deol A; Diaz MA; Farhadfar N; Freytes C; Gajewski J; Gandhi MJ; Ganguly S; Grunwald MR; Halter J; Hashmi S; Hildebrandt GC; Inamoto Y; Jimenez-Jimenez AM; Kalaycio M; Kamble R; Krem MM; Lazarus HM; Lazaryan A; Maakaron J; Munshi PN; Munker R; Nazha A; Nishihori T; Oluwole OO; Ortí G; Pan DC; Patel SS; Pawarode A; Rizzieri D; Saba NS; Savani B; Seo S; Ustun C; van der Poel M; Verdonck LF; Wagner JL; Wirk B; Oran B; Nakamura R; Scott B; Saber W
Transplant Cell Ther; 2022 Apr; 28(4):187.e1-187.e10. PubMed ID: 35081472
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
